Bernecker, M. et al. Weight cycling exacerbates glucose intolerance and hepatic triglyceride storage in mice with a history of chronic high fat diet exposure. J. Transl. Med. 23:7 (2025)
Krause, J.* et al. An arrhythmogenic metabolite in atrial fibrillation. J. Transl. Med. 21:566 (2023)
Schmitz, T.* et al. Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction. J. Transl. Med. 20:457 (2022)
Harman, N.L.* et al. Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes. J. Transl. Med. 18:468 (2020)
Körber, N. ; Behrends, U. ; Protzer, U. & Bauer, T. Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting. J. Transl. Med. 18:242 (2020)
Bao, X. ; Anastasov, N. ; Wang, Y.* & Rosemann, M. A novel epigenetic signature for overall survival prediction in patients with breast cancer. J. Transl. Med. 17:380 (2019)
Wen, W.* et al. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. J. Transl. Med. 17:186 (2019)
Gary, R.* et al. Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. J. Transl. Med. 16:124 (2018)
Slotta-Huspenina, J.* et al. Correction: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus [J Transl Med., 16, (2018) (109)] DOI: 10.1186/s12967-018-1492-9. J. Transl. Med. 16:128 (2018)
Halama, A.* et al. Measurement of 1,5-anhydroglucitol in blood and saliva: From non-targeted metabolomics to biochemical assay. J. Transl. Med. 14:140 (2016)
Körber, N. ; Behrends, U. ; Hapfelmeier, A.* ; Protzer, U. & Bauer, T. Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring. J. Transl. Med. 14:175 (2016)
Halama, A.* et al. Metabolic signatures differentiate ovarian from colon cancer cell lines. J. Transl. Med. 13:223 (2015)
Grabe, H.J.* et al. Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J. Transl. Med. 12:144 (2014)
Mathew, S.* et al. Metabolomics of Ramadan fasting: An opportunity for the controlled study of physiological responses to food intake. J. Transl. Med. 12:161 (2014)
Roehnisch, T.* et al. Phage idiotype vaccination: First phase I/II clinical trial in patients with multiple myeloma. J. Transl. Med. 12:119 (2014)
Buhmann, R. et al. Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: Study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating phase I/II-trial. J. Transl. Med. 11:160 (2013)
Roehnisch, T.* et al. Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model. J. Transl. Med. 11:267 (2013)
Ruf, P.* et al. Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. J. Transl. Med. 10:219 (2012)
Spranger, S. ; Frankenberger, B. & Schendel, D.J. NOD/scid IL-2Rgnull mice: A preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo. J. Transl. Med. 10:30 (2012)
Beck, B.* et al. Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission. J. Transl. Med. 9:151 (2011)
Fox, B.A.* et al. Defining the critical hurdles in cancer immunotherapy. J. Transl. Med. 9:214 (2011)
Bürdek, M. et al. Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation. J. Transl. Med. 8:90 (2010)
Milani, V. et al. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy - a case report. J. Transl. Med. 7:50 (2009)
Butterfield, L.H.* et al. A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J. Transl. Med. 6:81 (2008)
Adam, C. ; Mysliwietz, J. & Mocikat, R. Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine. J. Transl. Med. 5:16 (2007)
Rüttinger, D.* et al. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: First clinical experience and evidence of an immune response. J. Transl. Med. 5:43 (2007)
Zobywalski, A. et al. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J. Transl. Med. 5:18 (2007)
Geiger, C. ; Regn, S. ; Weinzierl, A.* ; Nößner, E. & Schendel, D.J. A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma. J. Transl. Med. 3, 1-15 (2005)